Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07KAQ
|
|||
| Former ID |
DIB010310
|
|||
| Drug Name |
L19-IL-2 fusion protein
|
|||
| Synonyms |
Darleukin; Immunocytokine fusion protein, Bayer Schering; Immunocytokine fusion protein, Philogen; L19-IL-2 fusion protein, Bayer Schering; L19-IL-2 fusion protein, Philogen
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 2 | [1] | |
| Company |
Philogen SpA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026492) | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 665656). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.